Several experimental and clinical studies have provided evidence that chronic hepatitis C infection can contribute to and exacerbate insulin resistance through multiple pathogenic mechanisms, including hepatic steatosis, impairment of the insulin signaling pathway, and activation of inflammatory pathways; these can aggravate each other in a vicious cycle that can ultimately result in HCV-associated diabetes mellitus [34]. This evidence concerns the gene INS and Insulin resistance.